Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →

Clinical Trials Directory

Browse and search research studies sourced from ClinicalTrials.gov and our partner researchers.

49,174 studies found

Not Yet Recruiting
A Study of Elranatamab for Inhibitor Eradication in Patients With Hemophilia A

Conditions: Hemophilia A With Inhibitors

Chinese Academy of Medical Science and Blood Disease Ho...

View details
Recruiting
Multi-target Drugs Sequential Combination Therapy in Adults Patients With Newly Diagnosed Prima...

Conditions: ITP - Immune Thrombocytopenia

Ethics Committee of Hematology Hospital, Chinese Academ...

View details
Recruiting
A Single-Arm Phase Ⅱ Study of Fluzoparib Maintenance in Platinum-sensitive Advanced Triple-Nega...

Conditions: Platinum-sensitive, TNBC, Triple Negative Breast Cancer, BRCA1/2 Mutation or Not

Tianjin Medical University Cancer Institute and Hospita...

View details
Recruiting
An Exploratory Study on the Efficacy and Safety of Enlonstobart Combined With Concurrent Radiot...

Conditions: Uterine Cervical Neoplasms

Tianjin Cancer Hospital Airport Branch Tianjin

View details
Recruiting
Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV)

Conditions: Polycythemia Vera

Blood Diseases Hospital, Chinese Academy of Medical Sci...

View details
Recruiting
Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia V...

Conditions: Polycythemia Vera (PV)

Institute of Hematology & Blood Diseases Hospital, Chin...

View details
Recruiting
Analysis of Multimodal Psychosomatic Comorbidity Burden in Breast Cancer and Benefit Evaluation...

Conditions: Breast Neoplasms

First Teaching Hospital of Tianjin University of Tradit...

View details
Recruiting
NK Cells Plus ICI for SCLC Maintenance

Conditions: Small Cell Lung Cancer

Tianjin First Central Hospital Tianjin Tianjin Municipa...

View details
Recruiting
Metformin Inhibits DNMT3A Clonal Hematopoiesis in Acute Leukemia

Conditions: DNMT3A Gene Mutation

Blood Diseases Hospital Tianjin Tianjin Municipality

View details
Recruiting
MRD-positive AML Clinical Study

Conditions: AML, Adult

Blood Diseases Hospital Tianjin Tianjin Municipality

View details
Recruiting
Intermediate-dose HAD Regimen for CEBPA Double-mutated AML

Conditions: AML

Blood Hospital Tianjin Tianjin Municipality

View details
Not Yet Recruiting
A Study on the Efficacy of Different Doses of Oryz-Aspergillus Enzyme And Pancreatin Tablet in...

Conditions: Pancreatic Exocrine Insufficiency, Adul

Tianjin Medical University Cancer Institute and Hospita...

View details
Recruiting
Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leuke...

Conditions: AML, RUNX1-RUNX1T1 Fusion Protein Expression

Blood Diseases Hospital Tianjin Tianjin Municipality

View details
Not Yet Recruiting
BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnosed Amyloidosis (AL-004)

Conditions: AL Amyloidosis

Institute of Hematology and Blood Diseases Hospital Chi...

View details
Recruiting
HY001N for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy.

Conditions: Autoimmune Hemolytic Anemia (AIHA)

Institute of Hematology & Blood Diseases Hospital Tianj...

View details
Recruiting
A Study of Neoadjuvant Tislelizumab Plus Lenvatinib in Resectable HCC at High Risk of Recurrenc...

Conditions: HCC - Hepatocellular Carcinoma

Tianjin Medical University Cancer Institute & Hospital...

View details
Not Yet Recruiting
To Explore a Single-arm Phase II Study on Intestinal Microbiota Transplantation Combined With N...

Conditions: Locally Advanced Rectal Cancer (LARC)

Tianjin Medical University Cancer Institute & Hospital...

View details
Recruiting
CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL)

Tianjin Medical University Cancer Insititute & Hospital...

View details
Active Not Recruiting
AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC

Conditions: Resectable Non-small Cell Lung Cancer

Tianjin Medical University Cancer Institute & Hospital...

View details
Recruiting
Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct Tumors

Conditions: Biliary Tract Cancer (BTC)

Department of Radiation Oncology, Tianjin Medical Unive...

View details
Recruiting
HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

Conditions: Relapsed and Refractory Acute Myeloid Leukemia (RR-AML)

Institute of Hematology and Blood Diseases Hospital, Ti...

View details
Recruiting
BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma

Conditions: High Risk Smoldering Multiple Myeloma

Institute of Hematology and Blood Diseases Hospital Chi...

View details
Recruiting
BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis

Conditions: Systemic Light Chain Amyloidosis

Institute of Hematology and Blood Diseases Hospital Chi...

View details
Not Yet Recruiting
Early Response-guided Sequential Radiotherapy After Chemoimmunotherapy for Locally Advanced Eso...

Conditions: Esophageal Squamous Cell Carcinoma (ESCC)

Department of minimally invasive esophageal surgery, Ti...

View details